December 12, 2022 – Novant Health and Movano Health, a purpose-driven healthcare solutions company at the intersection of medical and consumer devices, announced the development of a beta program. In the program, approximately thirty Novant Health team members will evaluate the functionality and wearability of Movano Health’s first commercial product, a smart ring designed to track and analyze medical grade data and deliver insights to consumers across a wide spectrum of healthcare needs. Expected to begin this month, the beta program will prepare Movano Health for its direct-to-consumer product launch in the first half of 2023.
“Movano Health and Novant Health share the belief that healthcare should be simpler and more accessible, and we’re consistently looking for ways to improve our operations and ability to care for our patients remotely,” said Paula Kranz, VP Innovation Enablement, Novant Health. “We’re looking forward to our team members participating in the beta with Movano Health.”
“To help combat the rising rates of chronic conditions worldwide and the associated costs, we’re focused on developing technology that promotes prevention by providing medical-grade data in fresh, consumer-friendly ways,” said John Mastrototaro, CEO of Movano Health. “We believe our solution can serve as a tool consumers and healthcare professionals, like Novant Health, can use to proactively monitor and manage their health outside of visits to the doctor. Collecting feedback on our platform outside the lab, from medical industry professionals, will be an invaluable learning opportunity for us.”